Pfizer submits data to FDA for kids’ COVID vaccine

Pfizer Inc. and BioNTech SE announced on Tuesday that they have shared the data from the phase 2/3 trial of their coronavirus vaccine in ages five to 12 with the United States Food and Drug Administra…